Evidence map›Paper›PMID 35330650›Full record

ReviewHeart views : the official journal of the Gulf Heart Association

Cardiac Myosin Activation in the Treatment of Congestive Heart Failure: New Therapeutic Options and Review of Literature.

Arroj Ali, Ramy Abdelmaseih, Ravi Thakker, Mohammed Faluk, Syed Mustajab Hasan

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart views : the official journal of the Gulf Heart Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Arroj AliCollege of Medicine, University of Central Florida, Orlando, Florida, USA.
Ramy AbdelmaseihCollege of Medicine, University of Central Florida, Orlando, Florida, USA.
Ravi ThakkerDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
Mohammed FalukCollege of Medicine, University of Central Florida, Orlando, Florida, USA.
Syed Mustajab HasanCollege of Medicine, University of Central Florida, Orlando, Florida, USA.
University of Central Florida · USThe University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congestive heart failure (HF) remains a major cause of cardiac-related morbidity and mortality, despite major therapeutic advancements. A newer class of medications has recently been developed which targets the root cause of HF, which is reduced myocardial contractility. This article aims to highlight the cardiac myosin activator class of drugs and the trials to date highlighting their effects on HF outcomes.

Indexed as

Heart failuremyosinomecamtiv mecarbil

Identifiers

PMID35330650
PMCPMC8939388
OpenAlexW4211150888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.